Stock comparison
GILEAD SCIENCES, INC. is 3.0x more valuable than ARGENX SE by market capitalization ($167.49 B vs $56.28 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
GILD is larger
GILEAD SCIENCES, INC. is 3.0x more valuable than ARGENX SE by market capitalization ($167.49 B vs $56.28 B).
Market value leader
GILD
GILEAD SCIENCES, INC. is 3.0x more valuable than ARGENX SE by market capitalization ($167.49 B vs $56.28 B).
| Metric | GILD | ARGX |
|---|---|---|
| Market cap | $167.49 B | $56.28 B |
| US-listed rank | #92 | #296 |
| Revenue (latest FY) | $29.44B | - |
| Net income (latest FY) | $8.51B | - |
| Net margin | 28.9% | - |
| P/E (trailing FY) | 19.7x | - |
| SEC filings | 968 | 272 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
GILEAD SCIENCES, INC. is 3.0x more valuable than ARGENX SE by market capitalization ($167.49 B vs $56.28 B).
Full pages: GILEAD SCIENCES, INC. and ARGENX SE, or browse the full rankings.